IFNG and pancreatic neuroendocrine tumor: After 2 weeks treatment of anti-PD-L1 plus anti-VEGFR2, the level of IFN-γ+ CD8+ and IFN-γ+ CD4+ T cell increased by twofold in pancreatic neuroendocrine tumor and mammary carcinoma.